BRCA2, Fanconi anemia complementation group protein C (FANCC) and a combination of FANCC and Fanconi anemia complementation group protein G (FANCG) mutations have been found in pancreatic cancer patients [68,69]. This evidence concerns the gene FANCC and familial pancreatic carcinoma.